Avita Medical
RCEL
82 hedge funds and large institutions have $117M invested in Avita Medical in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 14 closing their positions.
19% more capital invested
Capital invested by funds: $98.2M → $117M (+$19.1M)
0.46% more ownership
Funds ownership: 28.01% → 28.47% (+0.46%)
8% less call options, than puts
Call options by funds: $410K | Put options by funds: $446K
2% less funds holding
Funds holding: 84 → 82 (-2)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
14% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 28
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$7.13M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
+$3.91M |
| 3 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
+$2.08M |
| 4 |
Goldman Sachs
New York
|
+$860K |
| 5 |
Rafferty Asset Management
New York
|
+$835K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$5.28M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.87M |
| 3 |
Morgan Stanley
New York
|
-$1.37M |
| 4 |
BlackRock
New York
|
-$916K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$813K |
RCEL Hedge Fund Activity: Q1 2024 in Review
82 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q1 2024, worth a combined $117M — up 19% from $98.2M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of RCEL and 12 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 24 added.
The largest buyer was State Street, adding an estimated $7.13M. The largest seller was Pura Vida Investments, cutting an estimated $5.28M.
- 82 institutional investors held Avita Medical (RCEL) as of Q1 2024, down from 84 in Q4 2023.
- Funds reported $117M of Avita Medical stock for Q1 2024, up 19% quarter-over-quarter.
- 12 funds opened new Avita Medical positions in Q1 2024 and 14 closed out, a net change of -2 holders.
- The largest Avita Medical buyer in Q1 2024 was State Street, an estimated $7.13M added.
- The largest Avita Medical seller in Q1 2024 was Pura Vida Investments, an estimated $5.28M sold.
Based on aggregated 13F filings for Q1 2024.